Literature DB >> 24824185

Adipocyte induced arterial calcification is prevented with sodium thiosulfate.

Neal X Chen1, Kalisha O'Neill2, Nader Kassis Akl2, Sharon M Moe3.   

Abstract

BACKGROUND: Calcification can occur in fat in multiple clinical conditions including in the dermis, breasts and in the abdomen in calciphylaxis. All of these are more common in patients with advanced kidney disease. Clinically, hyperphosphatemia and obesity are risk factors. Thus we tested the hypothesis that adipocytes can calcify in the presence of elevated phosphorus and/or that adipocytes exposed to phosphorus can induce vascular smooth muscle cell (VSMC) calcification.
METHODS: 3T3-L1 preadipocytes were induced into mature adipocytes and then treated with media containing high phosphorus. Calcification was assessed biochemically and PCR performed to determine the expression of genes for osteoblast and adipocyte differentiation. Adipocytes were also co-cultured with bovine VSMC to determine paracrine effects, and the efficacy of sodium thiosulfate was determined.
RESULTS: The results demonstrated that high phosphorus induced the calcification of differentiated adipocytes with increased expression of osteopontin, the osteoblast transcription factor Runx2 and decreased expression of adipocyte transcription factors peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT-enhancer-binding protein α (CEBPα), indicating that high phosphorus led to a phenotypic switch of adipocytes to an osteoblast like phenotype. Sodium thiosulfate, dose dependently decreased adipocyte calcification and inhibited adipocyte induced increase of VSMC calcification. Co-culture studies demonstrated that adipocytes facilitated VSMC calcification partially mediated by changes of secretion of leptin and vascular endothelial growth factor (VEGF) from adipocytes.
CONCLUSION: High phosphorus induced calcification of mature adipocytes, and adipocytes exposed to elevated phosphorus can induce calcification of VSMC in a paracrine manner. Sodium thiosulfate inhibited this calcification and decreased the secretin of leptin and VEGF from adipocytes. These results suggest that adipocyte exposure to elevated phosphorus may be a pathogenic factor in calcification observed in the skin in calciphylaxis and other diseases.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipocytes; Calcification; Calciphylaxis; Leptin; Sodium thiosulfate; Vascular smooth muscle cells

Mesh:

Substances:

Year:  2014        PMID: 24824185     DOI: 10.1016/j.bbrc.2014.05.005

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  The role of the gasotransmitter hydrogen sulfide in pathological calcification.

Authors:  Mariela Castelblanco; Sonia Nasi; Andreas Pasch; Alexander So; Nathalie Busso
Journal:  Br J Pharmacol       Date:  2019-07-24       Impact factor: 8.739

2.  Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility.

Authors:  Tomohiro Saito; Yuuki Mima; Motonori Sugiyama; Nozomi Miyazawa; Ayana Iida; Nobuhiro Kanazawa; Taihei Suzuki; Yasuto Shikida; Toma Hamada; Yukihiro Wada; Masahide Mizobuchi; Hirokazu Honda
Journal:  CEN Case Rep       Date:  2019-12-17

3.  A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors.

Authors:  Sagar U Nigwekar; Sophia Zhao; Julia Wenger; Jeffrey L Hymes; Franklin W Maddux; Ravi I Thadhani; Kevin E Chan
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

Review 4.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

Review 5.  Modulating Cell Fate as a Therapeutic Strategy.

Authors:  Brian Lin; Priya Srikanth; Alison C Castle; Sagar Nigwekar; Rajeev Malhotra; Jenna L Galloway; David B Sykes; Jayaraj Rajagopal
Journal:  Cell Stem Cell       Date:  2018-06-14       Impact factor: 24.633

6.  Ulceration and Necrosis of Fingers and Toes in an ESKD Patient.

Authors:  Raymond Simon Piggott; George Mellotte; Donal J Sexton
Journal:  Kidney360       Date:  2021-06-24

7.  Perioperative Management of Calciphylaxis: Literature Review and Treatment Recommendations.

Authors:  Natalie Strand; Jillian Maloney; Samuel Wu; Molly Kraus; Rick Schneider; Diego Gomez; Steven Char
Journal:  Orthop Rev (Pavia)       Date:  2022-08-25

8.  Skeletal muscle metabolic responses to physical activity are muscle type specific in a rat model of chronic kidney disease.

Authors:  Keith G Avin; Meghan C Hughes; Neal X Chen; Shruthi Srinivasan; Kalisha D O'Neill; Andrew P Evan; Robert L Bacallao; Michael L Schulte; Ranjani N Moorthi; Debora L Gisch; Christopher G R Perry; Sharon M Moe; Thomas M O'Connell
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

9.  Positive Association of Leptin and Artery Calcification of Lower Extremity in Patients With Type 2 Diabetes Mellitus: A Pilot Study.

Authors:  SanBao Chai; Yao Chen; SiXu Xin; Ning Yuan; YuFang Liu; JianBin Sun; XiangYu Meng; YongFen Qi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-19       Impact factor: 5.555

10.  Non-Uremic Calciphylaxis: An Unexpected Complication With Recombinant Human Parathyroid Hormone.

Authors:  Cory DeClue; Bhavana Chinnakotla; Michael J Gardner
Journal:  Cureus       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.